Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
GLP-1 agonists are not expensive to produce, however, and the patent on Ozempic expired in January of 2026 in Canada and China (and lasts until 2030 in the U.S.), but I expect the market to bring the costs down dramatically over the next few years
UK availability will depend on MHRA review and approval, and timelines haven't been confirmed
Viking Therapeutics VK2735 Viking Therapeutics is emerging as a significant player in the competitive obesity market with its drug candidate, VK2735
Research suggests that L-cells are most responsive to nutrients during specific time windows, and that extended fasting periods may enhance L-cell sensitivity
US$ 26.93
US$ 22.38
US$ 20.00
US$ 22.80
US$ 26.11
